Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ligand Pharmaceuticals | LGND | Jan 10, 2025 | 106.28 | -3.89 |
Light & Wonder | LNW | Jan 10, 2025 | 85.25 | -0.34 |
Lightbridge | LTBR | Jan 10, 2025 | 5.98 | +10.54 |
LightInTheBox Holding ADR | LITB | Jan 10, 2025 | 1.38 | -6.12 |
LightPath Technologies A | LPTH | Jan 10, 2025 | 3.13 | -5.15 |
Lightspeed Commerce | LSPD | Jan 10, 2025 | 14.79 | -3.84 |
Lightwave Logic | LWLG | Jan 10, 2025 | 1.94 | -12.22 |
Lilium N.V. A | LILM | Jan 10, 2025 | 0.08 | 0.00 |
Limbach | LMB | Jan 10, 2025 | 96.10 | -1.10 |
Limoneira | LMNR | Jan 10, 2025 | 23.04 | -4.40 |
Lincoln Educational Services | LINC | Jan 10, 2025 | 14.50 | -3.20 |
Lincoln Electric | LECO | Jan 10, 2025 | 180.51 | -2.66 |
Lincoln National | LNC | Jan 10, 2025 | 30.06 | -4.30 |
Lincoln National Pref | LNC-D | Jan 10, 2025 | 27.21 | -0.66 |
Lindblad Expeditions | LIND | Jan 10, 2025 | 11.61 | -1.11 |
Linde | LIN | Jan 10, 2025 | 414.15 | -1.40 |
Lindsay | LNN | Jan 10, 2025 | 123.06 | -0.16 |
Lineage | LINE | Jan 10, 2025 | 55.47 | -1.77 |
Lineage Cell Therapeutics | LCTX | Jan 10, 2025 | 0.58 | +8.98 |
Linkage Global A | LGCB | Jan 10, 2025 | 0.38 | -8.01 |
Linkbancorp | LNKB | Jan 10, 2025 | 7.00 | -2.37 |
Linkers Industries | LNKS | Jan 10, 2025 | 1.26 | 0.00 |
Lion ADR | LGHL | Jan 10, 2025 | 0.18 | +0.67 |
Lion Electric | LEV | Jan 10, 2025 | 0.25 | 0.00 |
Lionheart Units | CUBWU | Jan 10, 2025 | 10.02 | 0.00 |
Lions Gate Entertainment A | LGF-A | Jan 10, 2025 | 8.30 | -0.48 |
Lions Gate Entertainment B | LGF-B | Jan 10, 2025 | 7.42 | -0.54 |
Lipella Pharmaceuticals | LIPO | Jan 10, 2025 | 2.90 | -8.52 |
Lipocine | LPCN | Jan 10, 2025 | 4.89 | -6.50 |
LiqTech International | LIQT | Jan 10, 2025 | 1.78 | -5.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.